St. Louis-based biotech startup C2N Diagnostics snags $2.2M in funding to advance Alzheimer's blood test

St. Louis Business Journal

Sep 24, 2020

St. Louis-based biotechnology startup C2N Diagnostics, which has created a blood test designed to detect Alzheimer's disease, has received approximately $2.2 million in funding fro…